Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 7;6(8):e70122.
doi: 10.1002/mco2.70122. eCollection 2025 Aug.

Meal-Induced NF-kB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease

Affiliations

Meal-Induced NF-kB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease

Giovanni Musso et al. MedComm (2020). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Giovanni Musso: no present or past financial or non‐financial competing interest to disclose. Filippo Mariano: no present or past financial or non‐financial competing interest to disclose. Mella Alberto: no present or past financial or non‐financial competing interest to disclose. Silvia Pinach: no present or past financial or non‐financial competing interest to disclose. Roberto Gambino: no present or past financial or non‐financial competing interest to disclose.

Figures

FIGURE 1
FIGURE 1
Meal tolerance test parameters. Data are presented as mean (SEM). (A) Correlation between postprandial NF‐kB activation in mononuclear cells (MNCs) and absolute values of eGFR and of AER in MASLD patients (cross‐sectional cohort, n = 85). (B) Plasma Monocyte Chemoattractant Protein (MCP)‐1 and Lumican during the standardized meal tolerance test. Patients (n = 52) were grouped according to the presence (n = 32) or absence (n = 20) of chronic kidney disease (CKD) at baseline. (C) Correlation between changes (%) in postprandial NF‐kB activation in MNCs and changes in absolute values of eGFR and of AER in MASH patients, grouped according to treatment arm (n = 52).

Similar articles

References

    1. Musso G., Gambino R., Tabibian J. H., et al., “Association of Non‐Alcoholic Fatty Liver Disease With Chronic Kidney Disease: A Systematic Review and Meta‐Analysis,” Plos Medicine 11 (2014): e1001680. - PMC - PubMed
    1. Sun D. Q., Targher G., Byrne C. D., et al., “An International Delphi Consensus Statement on Metabolic Dysfunction‐Associated Fatty Liver Disease and Risk of Chronic Kidney Disease,” Hepatobiliary Surgery and Nutrition 12 (2023): 386–403. - PMC - PubMed
    1. Hofmann M. A., Schiekofer S., Kanitz M., et al., “Insufficient Glycemic Control Increases Nuclear Factor‐Kappa B Binding Activity in Peripheral Blood Mononuclear Cells Isolated From Patients With Type 1 Diabetes,” Diabetes Care 21 (1998): 1310–1316. - PubMed
    1. Musso G., Pinach S., Mariano F., et al., “Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis a Randomized, Double‐blind, Placebo‐Controlled Trial,” Hepatology 81, no. 2 (2025): 560–575. - PubMed
    1. Nie H., Yang H., Cheng L., and Yu J., “Identification of Lipotoxicity‐Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis,” Journal of Diabetes Research 2024 (2024): 5550812. - PMC - PubMed

LinkOut - more resources